Schedule 13G ownership disclosure

Cytori Therapeutics Inc Com New

Security class unavailable · CUSIP: 23283K204

Event date: 2017-02-15

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
5.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001564590-17-002414
Form type
SC 13G
Filer
Azaya Therapeutics Inc
CIK
CIK 1411552
Filed
Feb 24, 2017
Reporting period
Feb 15, 2017
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub